Ledger entry · candidate
Fezolinetant → Insomnia — Audit-grade candidate (scan)
Drug: fezolinetant · AE: Insomnia
Discovered via single-drug scan of fezolinetant. PRR = 3.10 (95% CI 2.53–3.81), n = 87 cases. Pre-reg locked at submission time.
Disproportionality
- PRR: 3.1017550686610833
(95% CI 2.53–3.81)
- Yates χ2: 123.56128667821382
- Cases (case-drug + AE): n = 87
- Verdict:
PASSES_ALL_GATES — PRR=3.10 (95% CI 2.53–3.81), n=87 cases; flagged for clinical expert review, NOT for external escalation without manual verification
Top reactions in cohort
| MedDRA PT | n |
| No reactions surfaced in cohort. |
Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.